The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
89 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $21,880,770 in first-year total cost, median $229,500.
Most frequent study sections
- Special Emphasis Panel[ZAI1 EC-M (J1)]9
- Special Emphasis Panel[ZAI1 KP-M (J1)]8
- Special Emphasis Panel[ZAI1 BLF-M (S1)]7
- Special Emphasis Panel[ZAI1 UKS-M (S1)]6
- Special Emphasis Panel[ZAI1 ALW-M (S1)]5
Most frequent institutions
- UNIVERSITY OF CALIFORNIA AT DAVIS7
- COLORADO STATE UNIVERSITY4
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI4
- UNIVERSITY OF TEXAS MED BR GALVESTON4
- UNIVERSITY OF WISCONSIN-MADISON4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | A Novel Conformation of the ZIKV Protease Provides a Unique 3D Scaffold for Discovering Allosteric Protease Inhibitors as Direct Anti-virals, via HT and Virtual Screening, and Protein Engineering1R21AI134581-01 | LIDDINGTON, ROBERT COLIN | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $292,500 | ZAI1 |
| 2018 | Rescuing Neurodevelopment in Zika-exposed Children1R21HD093551-01 | FERNANDES, MICHELLELANDON, BARBARAWAECHTER, RANDALL | WINDWARD ISLANDS RESEARCH & ED FDN, NY | $137,500 | ZHD1 |
| 2017 | Development of a nonhuman primate model of fetal Zika virus infection and disease1R21AI129479-01 | VAN ROMPAY, KOEN K | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $1,786,954 | ZAI1 |
| 2017 | A Novel Vaccine Platform for Preventing Zika Virus Infection1R21AI134495-01 | MARKHAM, RICHARD B. | JOHNS HOPKINS UNIVERSITY, MD | $286,125 | ZAI1 |
| 2017 | Prevention of Zika transmission with novel Aedes personal protective measures1R21AI130521-01 | CARLIER, PAUL RGRIECO, JOHN PAULSCHETZ, JOHN A | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $276,530 | ZAI1 |
| 2017 | Deep mutational scanning of the Zika envelope protein1R21AI133649-01 | EVANS, MATTHEW J | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $274,277 | ZAI1 |
| 2017 | Evaluating the Presence of Zika Virus in Neotropical Primates1R21AI129505-01 | DI FIORE, ANTHONY FRANCISDUDLEY, JAQUELIN PAGEMEYERS, LAUREN ANCELPAYNE, SHELLEY M. | UNIVERSITY OF TEXAS AT AUSTIN, TX | $273,875 | ZAI1 |
| 2017 | Mapping the RNA modification N6-methyladenosine during Zika virus infection1R21AI129851-01 | HORNER, STACY MICHELLEMASON, CHRISTOPHER EDWARD | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $263,750 | ZAI1 |
| 2017 | Placental Defenses against Zika Virus Infection1R21AI134576-01 | KUOHUNG, WENDY | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $258,196 | ZAI1 |
| 2017 | Interferon signaling inhibition by the Zika virus NS5 protein1R21AI129486-01 | GARCIA-SASTRE, ADOLFO | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $254,250 | ZAI1 |
| 2017 | ZIKA VIRUS RESISTANCE; HOST DETERMINANTS1R21AI129827-01 | BOGUNOVIC, DUSAN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $254,250 | ZAI1 |
| 2017 | Determining West Nile virus antibody-dependent enhancement of Zika virus1R21AI130299-01 | LIM, JEAN KYOU | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $252,993 | ZAI1 |
| 2017 | Clinical Outcomes of Zika Virus in Sickle Cell Disease1R21HL137439-01 | KELLY, SHANNON | VITALANT, AZ | $252,694 | ZHL1 |
| 2017 | Dental and Craniofacial Effects of Intrauterine Zika Virus Infection1R21DE027235-01 | CAMPOS-RIVERA, MARIBEL | UNIVERSITY OF PUERTO RICO MED SCIENCES, PR | $251,882 | ZDE1 |
| 2017 | Innate antiviral defense against Vaginal transmission of ZIKA virus1R21AI131284-01 | IWASAKI, AKIKO | YALE UNIVERSITY, CT | $251,250 | ZAI1 |
| 2017 | Zika Virus Vaccines based on Nanoscale Constructs Presenting the Envelope Protein1R21AI129477-01 | KANE, RAVI S. | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $250,187 | ZAI1 |
| 2017 | Role of autophagy for Zika virus lifecycle1R21AI129496-01 | JUNG, JAE U | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $247,500 | ZAI1 |
| 2017 | Effects of pre-existing dengue virus immunity on Zika virus infection1R21AI129881-01 | COLPITTS, TONYA MICHELLE | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $246,750 | ZAI1 |
| 2017 | Construction of a ZIKV-host protein-protein interaction network1R21AI131706-01 | ZHU, HENG | JOHNS HOPKINS UNIVERSITY, MD | $245,282 | ZAI1 |
| 2017 | Innate Immune Inhibition of the Mevalonate Pathway Impairs Neurodevelopment during ZIKV Infection1R21NS102628-01 | WANG, DONGHAI | DUKE UNIVERSITY, NC | $238,500 | ZNS1 |
| 2017 | In vivo efficacy studies of existing drugs re-purposed for flaviviruses in mouse models1R21AI133219-01 | LI, HONGMIN | WADSWORTH CENTER, NY | $238,240 | ZAI1 |
| 2017 | Antiviral immunity in the Zika virus mosquito vector1R21AI129863-01 | ANDINO, RAUL | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $237,750 | ZAI1 |
| 2017 | Role of Persistent Zika Virus Infection of Endothelial Cells in Pathogenesis1R21AI131729-01 | MACKOW, ERICH R | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $235,543 | ZAI1 |
| 2017 | Microbial interplay between ZIKA virus and the native microbiome in mosquitoes1R21AI129507-01 | HUGHES, GRANT LESLIE | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $235,500 | ZAI1 |
| 2017 | New Use of Old Drugs for Zika Virus1R21AI134568-01 | LI, HONGMIN | WADSWORTH CENTER, NY | $235,470 | ZAI1 |
| 2017 | Pregnant rabbits as a model to evaluate the causative role of ZIKV infection in the etiology of congenital malformations1R21AI129852-01 | STAATS, HERMAN F | DUKE UNIVERSITY, NC | $235,406 | ZAI1 |
| 2017 | Discovering host factors impacting ZIKV infection via forward genetic screens1R21AI129531-01 | BATES, PAUL | UNIVERSITY OF PENNSYLVANIA, PA | $235,388 | ZAI1 |
| 2017 | Repurposing drugs to prevent and inhibit Zika virus inflections1R21AI129607-01 | SCHINAZI, RAYMOND FELIX | EMORY UNIVERSITY, GA | $234,000 | ZAI1 |
| 2017 | Identification and evaluation of novel therapeutic strategies for Zika virus-induced CNS disease1R21NS103186-01 | TYLER, KENNETH L. | UNIVERSITY OF COLORADO DENVER, CO | $233,250 | ZNS1 |
| 2017 | Structure based design of recombinant Zika virus antigens for serodiagnosis1R21AI134073-01 | DESILVA, ARAVINDA M.LAKSHMANANE, PREMKUMAR | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $233,250 | ZAI1 |
| 2017 | Targeting Zika Virus Infection with Chloroquine and Related Drugs1R21AI130281-01 | FINK, SUSAN LEILANI | UNIVERSITY OF WASHINGTON, WA | $232,625 | ZAI1 |
| 2017 | Zika Virus Pathogenesis and Selective Autophagy Induction to Inhibit Virus Production1R21AI129846-01 | SPECTOR, DEBORAH HYE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $232,500 | ZAI1 |
| 2017 | Mechanisms of sexual Zika virus transmission and early immunopathogenesis1R21AI129303-01 | VOJTECH, LUCIA N | UNIVERSITY OF WASHINGTON, WA | $232,063 | ZAI1 |
| 2017 | Rapid Phenotyping of the ZIKV Genome1R21AI129369-01 | ZHAO, RICHARD YUQI | UNIVERSITY OF MARYLAND BALTIMORE, MD | $231,750 | ZAI1 |
| 2017 | Under attack: Modulation of the blood-testes barrier by Zika virus1R21AI129465-01 | VERMA, SAGUNA | UNIVERSITY OF HAWAII AT MANOA, HI | $231,000 | ZAI1 |
| 2017 | Determining the role of host lipids in Zika virus infection1R21AI133631-01 | TAFESSE, FIKADU G. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $231,000 | ZAI1 |
| 2017 | Functional analysis of Zika virus induced birth defects1R21AI131418-01 | SHEETS, MICHAEL D | UNIVERSITY OF WISCONSIN-MADISON, WI | $229,500 | ZAI1 |
| 2017 | Zika virus evolutionary dynamics in host adaptation1R21AI131454-01 | ALIOTA, MATTHEW T | UNIVERSITY OF WISCONSIN-MADISON, WI | $229,500 | ZAI1 |
| 2017 | Understanding pathogenic noncoding RNA production in Zika Virus infection1R21AI129569-01 | KIEFT, JEFFREY S | UNIVERSITY OF COLORADO DENVER, CO | $229,125 | ZAI1 |
| 2017 | A Nanoscale Plasmonic-Gold Platform for Specific Diagnosis of Zika and Differentiation from other Flavivirus Infections1R21AI131689-01 | ANANTA, JEYARAMAPINSKY, BENJAMIN | NIRMIDAS BIOTECH, INC., CA | $229,113 | ZAI1 |
| 2017 | PATHOGENESIS OF OCULAR ZIKA VIRUS INFECTION1R21EY027870-01 | APTE, RAJENDRA SMINER, JONATHAN J | WASHINGTON UNIVERSITY, MO | $228,750 | ZAI1 |
| 2017 | A novel system using human fetal brain neural stem cell to model ZIKV infection1R21AI129509-01 | WU, PING | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $228,650 | ZAI1 |
| 2017 | Viral and host determinants of Zika virus tissue tropism1R21AI129431-01 | LAZEAR, HELEN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $228,000 | ZAI1 |
| 2017 | Role of cell tropism for Zika virus transmission and pathogenesis1R21AI129593-01 | EBEL, GREGORY DAVID | COLORADO STATE UNIVERSITY, CO | $227,250 | ZAI1 |
| 2017 | Role of Post-transcription RNA Modifications on Zika Virus Gene Expression1R21AI133617-01 | FABRIS, DANIELEPAGER, CARA THERESIA | STATE UNIVERSITY OF NEW YORK AT ALBANY, NY | $226,813 | ZAI1 |
| 2017 | Social-ecological factors influencing receptivity to Zika virus and the efficacy of interventions in communities along the Texas-Mexico border1R21AI128953-01 | HAMER, GABRIEL LEE | TEXAS A&M AGRILIFE RESEARCH, TX | $222,750 | ZAI1 |
| 2017 | Design and validation of a rapid assay for Zika virus in biofluids and insect vectors1R21AI129488-01 | ROVNAK, JOEL | COLORADO STATE UNIVERSITY, CO | $222,546 | ZAI1 |
| 2017 | Pathological Implications of Repression of Cellular RNA Decay by Zika Virus1R21AI130497-01 | WILUSZ, JEFFREY | COLORADO STATE UNIVERSITY, CO | $222,436 | ZAI1 |
| 2017 | The Olive Baboon, a translational model for the study of Zika virus biology and pathogenesis1R21AI129560-01 | PAPIN, JAMES F | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $222,000 | ZAI1 |
| 2017 | The Olive Baboon model of Zika Virus induced fetal brain injury1R21NS103772-01 | MYERS, DEANPAPIN, JAMES F | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $222,000 | ZNS1 |
| 2017 | Nonhuman Primate Model to Assess Fetal Zika Virus Infection Complications1R21AI129308-01 | GOLOS, THADDEUS G | UNIVERSITY OF WISCONSIN-MADISON, WI | $221,550 | ZAI1 |
| 2017 | Diagnostic signatures of Zika virus pathogenesis1R21AI130523-01 | BLISH, CATHERINE A | STANFORD UNIVERSITY, CA | $219,762 | ZAI1 |
| 2017 | Zika virus urogenital tropism, pathogenesis and sexual transmission1R21AI129464-01 | FOY, BRIAN DAVID | COLORADO STATE UNIVERSITY, CO | $211,838 | ZAI1 |
| 2017 | Opthalmic Manifestations of Congenital Zika Virus Infection1R21EY028318-01 | BRASIL, PATRICIANIELSEN, KARINTSUI, IRENA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $211,475 | ZAI1 |
| 2017 | RNAi methods for Zika virus vector control1R21AI131427-01 | PALLI, SUBBA R | UNIVERSITY OF KENTUCKY, KY | $210,000 | ZAI1 |
| 2017 | Zika virus in the human genital tract and implications for transmission1R21AI129532-01 | BECKER-DREPS, SYLVIA IRENEBUCARDO, FILEMON | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $207,868 | ZAI1 |
| 2017 | Viral kinetics, immunity and transmission of ZIKV: an exploratory analysis in preparation for vaccine development1R21AI129534-01 | BRASIL, PATRICIANIELSEN, KARIN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $201,907 | ZAI1 |
| 2017 | Mucosal Single-Cycle Vaccines against Zika Virus1R21AI130298-01 | BARRY, MICHAEL A | MAYO CLINIC ROCHESTER, MN | $198,750 | ZAI1 |
| 2017 | Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling1R21AI129455-01 | CHIU, CHARLES YEN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $198,125 | ZAI1 |
| 2017 | Fetal Zika virus infection: role of the human placenta1R21AI129508-01 | HARRIS, EVAPEREIRA, LENORE PALMA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $197,523 | ZAI1 |
| 2017 | Preclinical development of candidate Zika virus vaccines using mouse models1R21AI129844-01 | BARRETT, ALAN D.T. | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $196,250 | ZAI1 |
| 2017 | Rapid development of neutralizing antiserum against Zika virus1R21AI132458-01 | LIU, RUIWU | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $196,250 | ZAI1 |
| 2017 | The role of the host ubiquitin system in Zika virus replication1R21AI132479-01 | RAJSBAUM, RICARDO | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $193,750 | ZAI1 |
| 2017 | Pre-clinical evaluation of a Zika virus vaccine1R21AI130180-01 | GAMBOTTO, ANDREA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $193,332 | ZAI1 |
| 2017 | Development of plant-derived, resistance-breaking mosquitocides for controlling vectors of Zika virus1R21AI129951-01 | PIERMARINI, PETER MRAKOTONDRAIBE, LIVA HARINANTENAINA | OHIO STATE UNIVERSITY, OH | $193,125 | ZAI1 |
| 2017 | Imaging and Trafficking of Neurotropic Virus in Maternal/Fetal Nonhuman Primates1R21AI133548-01 | TARANTAL, ALICE F | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $193,000 | ZAI1 |
| 2017 | Congenital Zika Syndrome and Postnatal Outcomes in Nonhuman Primates1R21NS103658-01 | HARTIGAN-O'CONNOR, DENNIS J.NOCTOR, STEPHEN CHARLESTARANTAL, ALICE F | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $193,000 | ZNS1 |
| 2017 | Identify ZIKV host factors with an improved CRISPR-based genome-wide knockout screen1R21AI129471-01 | WU, HAOQUAN | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $191,250 | ZAI1 |
| 2017 | Modulation of Zika Virus Infection by Preexisting West Nile Virus Antibodies1R21AI131696-01 | JOSHI, ANJALI | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $191,250 | ZAI1 |
| 2017 | GORILLA ADENOVIRUS ZIKA VACCINE FOR HUMANS1R21AI131254-01 | CURIEL, DAVID TERRY | WASHINGTON UNIVERSITY, MO | $190,625 | ZAI1 |
| 2017 | A Guinea Pig Model of Zika Virus Disease1R21OD024896-01 | KUMAR, MUKESH | UNIVERSITY OF HAWAII AT MANOA, HI | $182,875 | ZAI1 |
| 2017 | Identifying genetic correlatesof Zika virus infection and transmission in US mosquitoes1R21AI131683-01 | CIOTA, ALEXANDER TIMOTHY | WADSWORTH CENTER, NY | $181,504 | ZAI1 |
| 2017 | Single-cycle infectious Zika viruses for the development of a live-attenuated vaccine1R21AI130500-01 | MARTINEZ-SOBRIDO, LUIS | UNIVERSITY OF ROCHESTER, NY | $180,457 | ZAI1 |
| 2016 | Development of an Innovative, Effective, RNA-based Vaccine for Zika Virus1R21AI128992-01 | STINCHCOMB, DAN THOMASVAN HOEVEN, NEAL SCOTT | ACCESS TO ADVANCED HEALTH INSTITUTE, WA | $312,550 | ZAI1 |
| 2016 | A NHP model for vaginal Zika Virus transmission1R21OD023818-01 | MILLER, CHRISTOPHER JAMES | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $312,234 | ZAI1 |
| 2016 | Host-pathogen interactions in ZIKV infection leading to microcephaly1R21NS100477-01 | SHRESTA, SUJANSTRONGIN, ALEX YTERSKIKH, ALEXEY V | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $307,250 | ZNS1 |
| 2016 | Novel Testing to Elucidate Reproductive Outcomes of ZIKV Infection - Olympics 20161R21HD090955-01 | BYINGTON, CARRIE L. | UNIVERSITY OF UTAH, UT | $302,000 | ZHD1 |
| 2016 | Development of a model for determining the causal relationship between Zika virus infection during pregnancy and fetal microcephaly.1R21HD091032-01 | STREBLOW, DANIEL N | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $262,500 | ZHD1 |
| 2016 | Structure-based Design of Zika Virus Inhibitors Targeting Envelope Glycoprotein (E)1R21AI129306-01 | JACOBS, AMY LYNNRIZZO, ROBERT C. | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $252,708 | ZAI1 |
| 2016 | Assessment of infection route and vulnerability of neural precursor classes to Zika virus1R21NS101151-01 | CONNOR, JOHN HHAYDAR, TARIK F | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $246,750 | ZNS1 |
| 2016 | Molecular and Antibody Detection of Zika Virus in Saliva at the Point of Care1R21DE026700-01 | BAU, HAIM H | UNIVERSITY OF PENNSYLVANIA, PA | $241,500 | ZDE1 |
| 2016 | Nonhuman Primate Model to Assess Embryonic Zika Virus Infection1R21HD091163-01 | GOLOS, THADDEUS G | UNIVERSITY OF WISCONSIN-MADISON, WI | $229,500 | ZHD1 |
| 2016 | A Rapid and Specific Diagnostic for Immunoglobulin Response to Zika Virus Exposure Based on De novo Designed Low Cost Hyper-stable Mini-Protein Epitopes1R21AI128950-01 | BAKER, DAVIDYAGER, PAUL | UNIVERSITY OF WASHINGTON, WA | $221,788 | ZAI1 |
| 2016 | Is Culex quinquefasciatus a vector of the Zika virus?1R21AI128931-01 | LEAL, WALTER S | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $220,350 | ZAI1 |
| 2016 | Role of type I interferon signaling in Zika virus infection of the brain1R21NS100182-01 | WEISS, SUSAN R | UNIVERSITY OF PENNSYLVANIA, PA | $201,250 | ZAI1 |
| 2016 | Zika virus infection of neural stem cells to model pathogen-induced microcephaly1R21NS100545-01 | HORNER, STACY MICHELLESILVER, DEBRA | DUKE UNIVERSITY, NC | $198,750 | ZNS1 |
| 2016 | Potential for mosquitoes in the United States to transmit Zika virus1R21AI128918-01 | RASGON, JASON L | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $196,500 | ZAI1 |
| 2016 | Leveraging Established Fetal Primate Models to Expedite ZIKV Investigations1R21OD023716-01 | BARRY, PETER ANOCTOR, STEPHEN CHARLESTARANTAL, ALICE F | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $193,000 | ZHD1 |
| 2016 | Development of a Recombinant Zika Virus Vaccine Based on Subunit Envelope (E) Amtigen Fused to a TLR5 Agonist (Flagellin)1R21AI128960-01 | LIU, GETUSSEY, LYNDA G | VAXINNATE CORPORATION, NJ | $118,261 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.